Allergan
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Allergan".

content
Allergan, Inc.
Type Public (NYSE: AGN)
Founded 1948
Headquarters Irvine, California
Key people David E.I. Pyott, Chairman of the Board, CEO, F. Michael Ball, President
Industry Pharmaceuticals
Products Botox, Acular, Alocril, Prevage, Avage, Tazorac, Juvederm, Lap-band, Easyband,Restasis, Alphagan, Ganfort, Hydrafill, Optive
Revenue $2.319 billion USD (▲ $29.1M FY 2005)
Employees 5,055
Website www.allergan.com
Allergan headquarters in Irvine
Allergan headquarters in Irvine

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

Contents

Profile

The company's most notable neurologic product is Botox , used around the world to treat a variety of debilitating disorders associated with muscle overactivity and also well-known -- under the tradenames Botox Cosmetic and Vistabel -- for the treatment of facial lines.

Its most important manufacturing plants are in Waco, Texas, Westport, Ireland and San Jose, Costa Rica.

History

1950 Allergan launched its first product, NASAL DROPS

1962 Allergan achieves $1 Million in eye care sales

1966 Worldwide Corporate Headquarters was established in Irvine by acquiring a 28 ACRE parcel of land

1970 Allergan becomes Publicly traded and achievees $10 Million in sales

1978 Started Mfg in Ireland

1980 Subsidiaries are in 30 countries and products are marketed in more than 100 countries sales reach $100 Million

1987 Allergan achieves $500 Million in sales

1995 Allergan achieves $1 Billion in sales

2002 Botox is born

2004 Allergan achieves $2 Billion in sales

2006 Allergan Achieves $3 Billion in sales

2006 Lap Band is born

2007 Breast implants developed(see "Inamed acquisition" below)

In March 2006, Allergan acquired aesthetic company, Inamed, to create a world leading aesthetic brand focused on facial aesthetics, breast aesthetics, and devices designed to treat obesity(lapband).

In February 2007, Allergan acquired the Swiss company Endoart SA based on the EPFL campus. It has special expertise in the field of telemetrically-controlled implants.

Allergan is reported to be investigating the cosmetic properties of Lumigan in clinical trials as of November 2007. [1]

Products

  • NATRELLE - Breast Implants (Silicone and Saline)
  • LUMIGAN - anti-glaucoma medication containing the active ingredient bimatoprost.
  • Alphagan P - anti-(glaucoma) medication containing the active ingredient (brimonidine)
  • ACULAR
  • ZYMAR
  • Combigan - anti-(glaucoma) medication containing a combination of active ingredients (brimonidine) and (timolol)
  • BOTOX - anti-spasm medication containing the active ingredient botulinum toxin.
    • BOTOX COSMETIC - anti-wrinkle cosmetic drug derived from botox
    • VISTABEL - anti-wrinkle cosmetic drug derived from botox
  • REFRESH - artificial tears containing carboxymethylcellulose
    • CELLUVISC
    • DRY EYE THERAPY
      • Sensitive
    • LACRI-LUBE
    • LIQUIGEL
    • PLUS
    • P.M.
    • REDNESS RELIEF
    • TEARS
    • OPTIVE - most advanced retail dry-eye treatment
  • RESTASIS - dry eye treatment containing cyclosporine.
    • JUVEDERM- used cosmetically for wrinkles and fine lines, also for lip augmentation
    • TAZORAC- for severe acne and psoriasis
This list is incomplete; you can help by expanding it.

External links

References

Citations

  1. ^ Wall Street Journal: Drug That Lengthens Eyelashes Sets Off Flutter RHONDA L. RUNDLE November 19, 2007; Page B1
© jGames.co.uk 2007 (some content from Wikipedia under GDL ) !-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->
Your Ad Here